Drug recall
BUPRENORPHINE HCl PF (C) INJECTABLE STRENGTHS: 0.15 mg/ml, 0.6 mg/ml NDC: 49452825301, G9064-0122-10
FDA recall event 65481 · Class II · Diamondback Drugs of Delaware, LLC
Key facts
| Event ID | 65481 |
|---|---|
| Recall numbers | V-220-2013 |
| Recalling firm | Diamondback Drugs of Delaware, LLC |
| Product type | Veterinary |
| Products | BUPRENORPHINE HCl PF (C) INJECTABLE STRENGTHS: 0.15 mg/ml , 0.6 mg/ml NDC: 49452825301, G9064-0122-10 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Diamondback Drugs is recalling Buprenorphine HCL PF (C) Injectable due to an issue with the long-term stability of the product. Use of the Buprenorphine HCL PF (C) Injectable may not deliver the level… |
| Initiation date | Jun 10, 2013 |
| Report date | Jul 3, 2013 |
| Termination date | May 6, 2014 |
| City | Scottsdale |
| State | AZ |
| Country | United States |
| FEI number | 3003542383 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: